Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences
Argenx has agreed to amass Forte Biosciences for $2.2 billion, the businesses stated, in a deal supposed to develop the ...
Tag: Buyout
Vertex Eyes Growth Past Cystic Fibrosis with Deliberate $10B Crinetics Buyout
Vertex Prescribed drugs has agreed to accumulate Crinetics Prescribed drugs for $10 billion money, the businesses mentioned, in a deal ...
The world's leading source for AI research, emerging technology, and the people building the future. Independent, rigorous, and always ahead.